سرمایه گذاری دارویی تامین
تیپیکو | Stocks - Tehran Stock Exchange (TSE)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 32,870 1.23
Close Price: 33,370
Income Statement
AGM
Interim
2026/09/08 Fiscal Year 2026/05/2112 Month | 2025/09/14 Fiscal Year 2025/05/2112 Month | 2024/09/08 Fiscal Year 2024/05/2012 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | - | - | 33.478 Trillion | |
Total Revenues | 69.836 Trillion | 51.499 Trillion | 33.478 Trillion | |
Gross Profit | 69.836 Trillion | 51.499 Trillion | 33.478 Trillion | |
General & Administrative Expenses | 1.595 Trillion | 821.547 Billion | 736.081 Billion | |
Operating Profit (Loss) | 68.241 Trillion | 50.314 Trillion | 32.742 Trillion | |
Profit Before Tax | 67.282 Trillion | 50.19 Trillion | 34.539 Trillion | |
Tax | 8.159 Billion | 14.664 Billion | 12.017 Billion | |
Net Profit (Loss) After Tax | 67.274 Trillion | 50.175 Trillion | 34.527 Trillion | |
Retained Earnings at Beginning of Period | 51.671 Trillion | 40.408 Trillion | 50.234 Trillion | |
Approved Dividends — Prior Year AGM | -41.8 Trillion | -33 Trillion | -42.46 Trillion | |
Transfer from Other Equity Items | 50.813 Billion | -2.207 Billion | -4.264 Billion | |
Allocable Profit | 77.196 Trillion | 57.581 Trillion | 42.297 Trillion | |
Other Reserves | 53.963 Billion | 5.91 Trillion | 1.889 Trillion | |
Approved Dividends — Current Year | 61.28 Trillion | 41.8 Trillion | 33 Trillion | |
Retained Earnings at End of Period | 15.862 Trillion | 9.871 Trillion | 7.408 Trillion | |
سود حاصل از سرمایه گذاریها | 69.836 Trillion | - | - | |
درآمد سود سهام | - | 45.589 Trillion | - | |
سود حاصل از فروش سرمایه گذاریها | - | 5.91 Trillion | - | |
سایر هزینه ها | - | 341.793 Billion | - | |
هزینه استهلاک | - | 20.785 Billion | - |